tofacitinib
Showing 76 - 100 of 258
Rheumatoid Arthritis Trial in London (Etanercept, tofacitinib)
Recruiting
- Rheumatoid Arthritis
- Etanercept
- tofacitinib
-
London, Ontario, CanadaRheumatology Clinic, St. Joseph's Health Care
May 10, 2022
Ulcerative Colitis Trial in Amiens (Aortic pulse wave velocity, carotid intima media thickness (CIMT))
Recruiting
- Ulcerative Colitis
- Aortic pulse wave velocity
- carotid intima media thickness (CIMT)
-
Amiens, FranceCHU Amiens
Jul 8, 2021
Rheumatoid Arthritis Trial in Abu Dhabi (Anti-TNF, JAK inhibitor)
Not yet recruiting
- Rheumatoid Arthritis
- Anti-TNF
- JAK inhibitor
-
Abu Dhabi, United Arab EmiratesAbu Dhabi Stem Cells Center
May 17, 2022
COVID-19 Trial in Moscow (Tofacitinib)
Completed
- COVID-19
- Tofacitinib
-
Moscow, Russian FederationSechenov First Moscow State Medical University (Sechenov Univers
Feb 11, 2021
Uveitis, Scleritis Trial in Saint Louis (tofacitinib)
Unknown status
- Uveitis
- Scleritis
- tofacitinib
-
Saint Louis, MissouriWashington University in Saint Louis
Jan 7, 2021
Covid19 Trial in Brazil (Tofacitinib 10 mg, Placebo)
Completed
- Covid19
- Tofacitinib 10 mg
- Placebo
-
Aracaju, Brazil
- +16 more
Aug 2, 2021
Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)
Recruiting
- Psoriatic Arthritis
- +2 more
- Prednisolone
- +14 more
-
Erlangen, Bavaria, GermanyUniversitätsklinikum Erlangen
Nov 10, 2022
Diaphragm Injury Trial in Stanford (Tofacitinib 5 mg, Placebo to match Tofacitinib)
Recruiting
- Diaphragm Injury
- Tofacitinib 5 mg
- Placebo to match Tofacitinib
-
Stanford, CaliforniaStanford University Medical Center
May 24, 2021
Dermatomyositis Trial in Baltimore (Tofacitinib)
Completed
- Dermatomyositis
- Tofacitinib
-
Baltimore, MarylandJohns Hopkins University
Nov 5, 2020
Diffuse Large B Cell Lymphoma Trial in Shanghai (Zanubrutinib plus R-ICE, Decitabine plus R-ICE, Chidamide plus R-ICE)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- Zanubrutinib plus R-ICE
- +4 more
-
Shanghai, Shanghai, ChinaRuijin Hospital
Apr 26, 2022
Ulcerative Colitis Trial in Seoul (Vedolizumab, Ustekinumab, or Tofacitinib)
Recruiting
- Ulcerative Colitis
- Vedolizumab, Ustekinumab, or Tofacitinib
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 14, 2022
Tofacitinib in Treatment-Resistant Rheumatoid Arthritis
Completed
- Rheumatoid Arthritis
- Treatment Adherence and Compliance
- (no location specified)
Dec 12, 2020
Healthy Trial in Merksem (Tofacitinib)
Completed
- Healthy
- Tofacitinib
-
Merksem, BelgiumClinical Pharmacology Unit
Oct 26, 2021
Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)
Recruiting
- Rheumatoid Arthritis
- Methotrexate
- +15 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Oct 28, 2021
Rheumatoid Arthritis Trial (Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD))
Not yet recruiting
- Rheumatoid Arthritis
- Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD)
- (no location specified)
Nov 12, 2021
Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis Trial in Birmingham, Omaha (Upadacitinib, Abatacept, Secukinumab)
Recruiting
- Rheumatoid Arthritis
- +2 more
- Upadacitinib
- +7 more
-
Birmingham, Alabama
- +7 more
Sep 19, 2022
Juvenile Idiopathic Arthritis Trial in Worldwide (Tofacitinib)
Recruiting
- Juvenile Idiopathic Arthritis
- Tofacitinib
-
Phoenix, Arizona
- +134 more
Jan 25, 2023
Healthy Trial in New Haven (tofacitinib modified release (MR))
Completed
- Healthy
- tofacitinib modified release (MR)
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Oct 27, 2020
Rheumatoid Arthritis Trial in Seoul (Tofacitinib)
Unknown status
- Rheumatoid Arthritis
- Tofacitinib
-
Seoul, Korea, Republic ofHanyang University
Jun 23, 2020
Ulcerative Colitis Trial in Worldwide (tofacitinib)
Recruiting
- Ulcerative Colitis
- tofacitinib
-
Phoenix, Arizona
- +92 more
Jan 25, 2023
Rheumatoid Arthritis Trial in Dhaka (Methotrexate, Tofacitinib)
Unknown status
- Rheumatoid Arthritis
- Methotrexate
- Tofacitinib
-
Dhaka, BangladeshBangabandhu Seikh Mujib Medical University
Jul 6, 2020
Healthy Trial in Shanghai (tofacitinib MR 11 mg, tofacitinib IR 5 mg)
Completed
- Healthy
- tofacitinib MR 11 mg
- tofacitinib IR 5 mg
-
Shanghai, ChinaShuguang Hospital Affiliated to Shanghai University of TCM/Phase
May 22, 2020
Takayasu Arteritis, Methotrexate, Inhibition Trial in Shanghai (Methotrexate Tablets, Tofacitinib tablet)
Recruiting
- Takayasu Arteritis
- +3 more
- Methotrexate Tablets
- Tofacitinib tablet
-
Shanghai, ChinaLindi Jiang
Jun 10, 2020